Vial Partners with Nielsen BioSciences Inc in Phase III Clinical Trial for the Treatment of Common Warts Drugscom MedNews

SAN FRANCISCO, June 14, 2023. Vial, a global tech-driven CRO providing next-generation clinical trial management services, has partnered with Nielsen BioSciences, Inc. (Nielsen), a privately-held biopharmaceutical company based in San Diego, CA, to study the safety and efficacy of CANDIN for the treatment of common warts. Nielsen focuses on developing…Read More